Camilo Santana Silva, Ronaldo Teixeira da Silva Júnior, Luana Kauany de Sá Santos, Jonathan Santos Apolonio, B. T. Costa, Beatriz Rocha Cuzzuol, Marcel Silva Luz, F. Melo
{"title":"Extragastric Manifestations of Helicobacter Pylori Infection: A Commentary","authors":"Camilo Santana Silva, Ronaldo Teixeira da Silva Júnior, Luana Kauany de Sá Santos, Jonathan Santos Apolonio, B. T. Costa, Beatriz Rocha Cuzzuol, Marcel Silva Luz, F. Melo","doi":"10.33696/gastroenterology.2.035","DOIUrl":null,"url":null,"abstract":"Helicobacter pylori (Hp) is characterized as a gram-negative bacterium with microaerophilic metabolism, flagellated and helix-shaped that affects approximately 50% of the world population and, in some regions, this rate can exceed 80% [1,2]. Hp infection is well known to infect the epithelial tissue of the stomach, being involved with development of many stomach diseases, including gastric carcinoma [3,4]. However, less frequently, this bacterium might also be involved in the development of extragastric disorders, such as manifestations in the gastrointestinal tract, except stomach, autoimmune, dermatological, ophthalmic and cardiac diseases, in addition to neurological, respiratory and endocrine diseases [5,6]. The article titled “Helicobacter pylori infection: beyond gastric manifestations” shows these possibilities [7].","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Gastroenterology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33696/gastroenterology.2.035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Helicobacter pylori (Hp) is characterized as a gram-negative bacterium with microaerophilic metabolism, flagellated and helix-shaped that affects approximately 50% of the world population and, in some regions, this rate can exceed 80% [1,2]. Hp infection is well known to infect the epithelial tissue of the stomach, being involved with development of many stomach diseases, including gastric carcinoma [3,4]. However, less frequently, this bacterium might also be involved in the development of extragastric disorders, such as manifestations in the gastrointestinal tract, except stomach, autoimmune, dermatological, ophthalmic and cardiac diseases, in addition to neurological, respiratory and endocrine diseases [5,6]. The article titled “Helicobacter pylori infection: beyond gastric manifestations” shows these possibilities [7].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
